Skip to content

Effectiveness of Adhesion and Safety of Oral Ulcer Patch Containing Standardized Centella asiatica Extract in Healthy Volunteers

Effectiveness of Adhesion and Safety of Oral Ulcer Patch Containing Standardized Centella asiatica Extract in Healthy Volunteers

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20251124002
Enrollment
20
Registered
2025-11-24
Start date
2025-06-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy human volunteers Oral ulcer patch Centella asiatica L. Patch retention Preliminary safety study MADESIA

Interventions

Participants were instructed to place the patch (MADESIA) with a diameter of 1.40 cm on the inner lower lip, pressing it gently for 3 seconds before releasing it.
Experimental Device
Oral Ulcer Patch Containing Standardized Centella asiatica Extract

Sponsors

PSU-Graduate Studies Scholarship
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years, 2. In good health, with no underlying medical conditions, 3. Non-smoker

Exclusion criteria

Exclusion criteria: 1. Currently wearing orthodontic appliances or dentures, 2. Presence of oral lesions, 3. Use of antihistamines, steroidal anti-inflammatory drugs, or NSAIDs within 2 weeks before enrollment, 4. Use of any oral ulcer patch within 2 weeks before enrollment, 5. Use of mouthwash within 2 weeks before enrollment, 6. Changing toothpaste within 2 weeks before enrollment, 7. A history of undergoing dental procedures within 2 weeks before enrollment, 8. Consumption of alcoholic beverages within 2 weeks before enrollment, 9. Known allergy to C. asiatica, A. vera, tamarind, sodium alginate, glycerin, coriander, or celery , 10. A diagnosis of xerostomia by a dentist, 11. Pregnancy or breastfeeding, 12. Inability to read and write in Thai (including numbers), 13. Concurrent participation in another research study

Design outcomes

Primary

MeasureTime frame
adverse events 7 days after end of the intervention frequency of adverse events,retention time 3 hours after end of the intervention retention time (minutes)

Secondary

MeasureTime frame
self-reported participant satisfaction 3 hours after end of the intervention Patient-reported outcome measure

Countries

Thailand

Contacts

Public ContactSupontep Treerakanok

Prince of Songkla University

supontep.t@psu.ac.th0968262465

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026